Maria Grazia Rumi

9.3k total citations · 1 hit paper
150 papers, 5.3k citations indexed

About

Maria Grazia Rumi is a scholar working on Hepatology, Epidemiology and Hematology. According to data from OpenAlex, Maria Grazia Rumi has authored 150 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Hepatology, 118 papers in Epidemiology and 17 papers in Hematology. Recurrent topics in Maria Grazia Rumi's work include Hepatitis C virus research (115 papers), Liver Disease Diagnosis and Treatment (86 papers) and Hepatitis B Virus Studies (82 papers). Maria Grazia Rumi is often cited by papers focused on Hepatitis C virus research (115 papers), Liver Disease Diagnosis and Treatment (86 papers) and Hepatitis B Virus Studies (82 papers). Maria Grazia Rumi collaborates with scholars based in Italy, United States and Switzerland. Maria Grazia Rumi's co-authors include Alessio Aghemo, E. Del Ninno, Maria Francesca Donato, Massimo Colombo, Guido Ronchi, Massimo Colombo, Roberta D’Ambrosio, R. Soffredini, R. Romeo and Massimo Colombo and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Annals of Internal Medicine.

In The Last Decade

Maria Grazia Rumi

149 papers receiving 5.1k citations

Hit Papers

Different clinical behaviors of acute hepatitis C virus i... 1996 2026 2006 2016 1996 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Grazia Rumi Italy 36 4.5k 4.2k 376 348 300 150 5.3k
Tobias Heintges Germany 28 3.3k 0.7× 2.9k 0.7× 213 0.6× 163 0.5× 269 0.9× 93 4.5k
M Reynès France 40 3.7k 0.8× 2.9k 0.7× 163 0.4× 469 1.3× 240 0.8× 155 5.6k
M. Rodríguez‐Torres United States 39 4.7k 1.0× 4.2k 1.0× 339 0.9× 326 0.9× 1.5k 4.9× 148 7.3k
Eiji Mita Japan 32 2.4k 0.5× 2.0k 0.5× 480 1.3× 275 0.8× 196 0.7× 120 3.3k
Kaname Yoshizawa Japan 33 3.0k 0.7× 3.2k 0.7× 1.1k 2.9× 377 1.1× 214 0.7× 124 4.7k
Gerd R. Pape Germany 33 4.0k 0.9× 3.3k 0.8× 478 1.3× 1.5k 4.3× 306 1.0× 67 5.2k
Hidenori Ochi Japan 36 2.3k 0.5× 2.7k 0.6× 237 0.6× 385 1.1× 351 1.2× 119 4.1k
David Booth Australia 21 1.8k 0.4× 1.5k 0.4× 473 1.3× 658 1.9× 183 0.6× 35 2.9k
Michitami Yano Japan 26 3.1k 0.7× 3.0k 0.7× 259 0.7× 176 0.5× 153 0.5× 63 3.6k

Countries citing papers authored by Maria Grazia Rumi

Since Specialization
Citations

This map shows the geographic impact of Maria Grazia Rumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Grazia Rumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Grazia Rumi more than expected).

Fields of papers citing papers by Maria Grazia Rumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Grazia Rumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Grazia Rumi. The network helps show where Maria Grazia Rumi may publish in the future.

Co-authorship network of co-authors of Maria Grazia Rumi

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Grazia Rumi. A scholar is included among the top collaborators of Maria Grazia Rumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Grazia Rumi. Maria Grazia Rumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casella, Giovanni, et al.. (2023). Approaches for Selective Vaccinations in Cirrhotic Patients. Vaccines. 11(2). 460–460. 5 indexed citations
2.
Viganò, Mauro, Nicola Pugliese, Federica Cerini, et al.. (2022). Accuracy of FIB-4 to Detect Elevated Liver Stiffness Measurements in Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Referral Centers. International Journal of Molecular Sciences. 23(20). 12489–12489. 16 indexed citations
3.
Loglio, Alessandro, Massimo Iavarone, G. Grossi, et al.. (2018). Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B. Alimentary Pharmacology & Therapeutics. 48(4). 431–439. 5 indexed citations
4.
Cheroni, Cristina, Lorena Donnici, Alessio Aghemo, et al.. (2015). Hepatitis C Virus Deletion Mutants Are Found in Individuals Chronically Infected with Genotype 1 Hepatitis C Virus in Association with Age, High Viral Load and Liver Inflammatory Activity. PLoS ONE. 10(9). e0138546–e0138546. 14 indexed citations
5.
D’Ambrosio, Roberta, Alessio Aghemo, Mirella Fraquelli, et al.. (2013). The diagnostic accuracy of Fibroscan® for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response. Journal of Hepatology. 59(2). 251–256. 111 indexed citations
6.
Nicola, Stella De, Alessio Aghemo, Roberta D’Ambrosio, et al.. (2013). Telaprevir in a Patient with Chronic Hepatitis C and Cryoglobulinemic Glomerulonephritis. Antiviral Therapy. 19(5). 527–531. 14 indexed citations
7.
Clark, Paul J., Alessio Aghemo, Elisabetta Degasperi, et al.. (2013). Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy. Journal of Viral Hepatitis. 20(12). 858–866. 27 indexed citations
8.
Dell’Osso, Bernardo, Carlotta Palazzo, Maria Grazia Rumi, et al.. (2012). Predictors of Psychopathological Outcome During Peg-Interferon and Ribavirin Therapy in Patients with Chronic HCV-Correlated Hepatitis. Journal of Interferon & Cytokine Research. 33(1). 9–14. 1 indexed citations
9.
Nicola, Stella De, Alessio Aghemo, Maria Grazia Rumi, et al.. (2011). Interleukin 28B Polymorphism Predicts Pegylated Interferon Plus Ribavirin Treatment Outcome in Chronic Hepatitis C Genotype 4. Hepatology. 55(2). 336–342. 67 indexed citations
10.
Romeo, R., E. Del Ninno, Maria Grazia Rumi, et al.. (2009). A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma. Gastroenterology. 136(5). 1629–1638. 236 indexed citations
11.
Federici, Augusto B., Elena Santagostino, Maria Grazia Rumi, et al.. (2006). The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease: a cohort study.. PubMed. 91(4). 503–8. 18 indexed citations
13.
Cammà, Calogero, Savino Bruno, V. Di Marco, et al.. (2005). Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C†. Hepatology. 43(1). 64–71. 130 indexed citations
14.
Filippi, Francesca, Pietro Lampertico, R. Soffredini, et al.. (2001). High prevalence, low pathogenicity in hepatitis G virus in kidney transplant recipients. Digestive and Liver Disease. 33(6). 477–479. 15 indexed citations
15.
Sangiovanni, Angelo, Giancarlo Spinzi, Maria Grazia Rumi, et al.. (1998). Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: A pilot randomized controlled study. Hepatology. 27(3). 853–856. 73 indexed citations
16.
18.
Filippi, Francesca, Massimo Colombo, Maria Grazia Rumi, et al.. (1997). High Rates of Hepatitis G Virus Infection in Multitransfused Patients With Hemophilia. Blood. 90(11). 4634–4637. 28 indexed citations
19.
Romeo, R., Maria Grazia Rumi, & Massimo Colombo. (1995). Alpha interferon treatment of chronic hepatitis C. Biomedicine & Pharmacotherapy. 49(3). 111–115. 16 indexed citations
20.
Brettler, DB, PM Mannucci, A. Gringeri, et al.. (1992). The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study. Blood. 80(2). 540–543. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026